Updates from the Journal of Virology Editors in Chief

Stacey Schultz-Cherry,Felicia Goodrum

DOI: https://doi.org/10.1128/jvi.01006-24

IF: 6.549

2024-06-26

Journal of Virology

Abstract:Journal of Virology, Ahead of Print.

virology

What problem does this paper attempt to address?

2023 Acknowledgment of Journal of Virology Ad Hoc Reviewers

Felicia Goodrum,Stacey Schultz-Cherry

DOI: https://doi.org/10.1128/jvi.01799-23

IF: 6.549

2024-02-21

Journal of Virology

Abstract:Journal of Virology, Volume 98, Issue 2, February 2024.

virology
Correction for Rasmussen et al., "Virology—the path forward"

Angela L. Rasmussen,Gigi K. Gronvall,Anice C. Lowen,Felicia Goodrum,James Alwine,Kristian G. Andersen,Simon J. Anthony,Joel Baines,Arinjay Banerjee,Andrew J. Broadbent,Christopher B. Brooke,Samuel K. Campos,Patrizia Caposio,Arturo Casadevall,Gary C. Chan,Anna R. Cliffe,Donna Collins-McMillen,Nancy Connell,Blossom Damania,Matthew D. Daugherty,Kari Debbink,Terence S. Dermody,Daniel DiMaio,W. Paul Duprex,Michael Emerman,Denise A. Galloway,Robert F. Garry,Stephen A. Goldstein,Alexander L. Greninger,Amy L. Hartman,Brenda G. Hogue,Stacy M. Horner,Peter J. Hotez,Jae U. Jung,Jeremy P. Kamil,Stephanie M. Karst,Lou Laimins,Seema S. Lakdawala,Igor Landais,Michael Letko,Brett Lindenbach,Shan-Lu Liu,Micah Luftig,Grant McFadden,Andrew Mehle,Juliet Morrison,Anne Moscona,Elke Mühlberger,Joshua Munger,Karl Münger,Eain Murphy,Christopher J. Neufeldt,Janko Z. Nikolich,Christine M. O'Connor,Andrew Pekosz,Sallie R. Permar,Julie K. Pfeiffer,Saskia V. Popescu,John G. Purdy,Vincent R. Racaniello,Charles M. Rice,Jonathan A. Runstadler,Martin J. Sapp,Rona S. Scott,Gregory A. Smith,Erin M. Sorrell,Emily Speranza,Daniel Streblow,Scott A. Tibbetts,Zsolt Toth,Koenraad Van Doorslaer,Susan R. Weiss,Elizabeth A. White,Timothy M. White,Christiane E. Wobus,Michael Worobey,Satoko Yamaoka,Andrew Yurochko

DOI: https://doi.org/10.1128/jvi.00074-24

IF: 6.549

2024-02-10

Journal of Virology

Abstract:Journal of Virology, Ahead of Print.

virology
The 15th Anniversary of Viruses: An Unwavering Commitment to Serving the Virology Community

Eric O. Freed

DOI: https://doi.org/10.3390/v16040486

2024-03-23

Viruses

Abstract:first_page Download PDF settings Order Article Reprints Font Type: Arial Georgia Verdana Font Size: Aa Aa Aa Line Spacing:    Column Width:    Background: Open Access Editorial The 15th Anniversary of Viruses : An Unwavering Commitment to Serving the Virology Community by Eric O. Freed Eric O. Freed SciProfiles Scilit Preprints.org Google Scholar HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA Viruses 2024 , 16 (4), 486; https://doi.org/10.3390/v16040486 Submission received: 18 March 2024 / Accepted: 20 March 2024 / Published: 22 March 2024 Download keyboard_arrow_down Download PDF Download PDF with Cover Download XML Download Epub Versions Notes It is often said that two things in life are certain: death and taxes. Even without a professional interest in the subject, one might be tempted in today's world to add a third: viruses.As Viruses celebrates its 15th anniversary, this Editorial is being written against the background of a so-called 'tripledemic'—the combination of influenza virus, SARS-CoV-2, and respiratory syncytial virus. This development has triggered an increase in hospital admissions of both the very young and the very old in Europe during the winter season [1]. However, despite how much we may know about viruses, there is always more to learn, there are always surprises around every corner, and there is always more work to be done in the fields of both primary research and public health management and communication.During the past decade and a half, I have had the privilege of being Editor-in-Chief of Viruses , which was first launched in 2009 [2]. It is a role in which I take both professional pride and considerable pleasure, working on a strictly volunteer basis with the goal of creating a highly regarded and influential scientific journal that serves the continually evolving needs of the global virology community.The field of virology has faced significant new challenges and has also witnessed exciting progress in recent decades. With a current impact factor of 4.7, Viruses itself has become a leader in the publication of high-quality virology papers. To date, the journal has published 13,690 papers, 5244 of which have been cited 10 times or more. Viruses has received an increased CiteScore of 7.1 according to the 2022 CiteScoresTM released by Elsevier in June 2023. This places it in the top quartile (Q1) of the 'Infectious Diseases' category. This is a significant development, as many authors use this metric when deciding where to submit their work.The success of Viruses as a well-recognized outlet for leading virology research is founded on the quality of its distinguished and highly committed editorial team, from the Editorial Board itself to the Reviewer Board to the editorial teams that prepare individual papers for publication. The journal has a broad scope that not only covers human and animal viruses but also insect, plant, and bacterial viruses. It is also very actively engaged in a number of outreach activities in the virology community, including conference organization, meeting sponsorships, early career investigator prizes, and travel awards, to name but a few. Every two years, we organize the Viruses conference to gather insights and exchange ideas with our peers in the field. The recent Viruses 2024 Conference, held in Barcelona, Spain, from 14 to 16 February 2024, was another significant milestone in this regard. Viru -Abstract Truncated-

virology
It's time for a booster: here's your 19th dose of Future Virology!

Ellen Porter

DOI: https://doi.org/10.2217/fvl-2024-0030

2024-03-21

Future Virology

Abstract:As is tradition, this issue will begin with some of the content highlights from last year. First, though, I'd like to take the opportunity to thank all our readers, authors and reviewers on behalf of the Future Virology team for their continued support and engagement with the journal. Last year, we were incredibly excited about the increase in the journal's impact factor to 3.1 (2022). We look forward to continuing to work together to grow the journal's impact in the upcoming year and bring you even more excellent content!

virology
Introducing Our New Journal: Infectious Microbes & Diseases

Stijn van der Veen,Lanjuan Li

DOI: https://doi.org/10.1097/im9.0000000000000005

2019-01-01

Infectious Microbes & Diseases

Abstract:Prof. Lanjuan Li Editor-in-ChiefThe 20th century has witnessed a steep decline of the global burden of infectious diseases due to improved hygiene conditions in large parts of the world and the introduction of vaccines and antimicrobials. However, in today's global landscape infectious diseases still remain a major concern. According to the 2017 Global Burden of Disease Study, communicable diseases still accounted for approximately 8.14 million deaths, which was 14.6% of all age deaths for that year.1 Furthermore, it accounted for 24% of all age years of life lost. Infectious disease outbreaks have been rising since the 1980s2 and pathogenic microbes are now spreading faster geographically due to international traveling. Simultaneously, emerging and re-emerging infectious diseases are being identified faster than ever before. The resurgence of these emerging and re-emerging diseases might be caused by climate change, changing international food chains, and a rise in antimicrobial resistance. According to a recent report on antimicrobial resistance issued by the UK government,3 unless proper action is taken, drug-resistant diseases might cause 10 million deaths per year by 2050, costing the global economy up to 100 trillion dollar. This is a daunting future scenario that we should be able to avert with joined global efforts and extensive surveillance, reporting and intensified fundamental and applied research on infectious microbes and diseases. Over the past decades, China has transformed itself into an international powerhouse with an economic aggregate that has become the second-largest in the world. As a result, China's science and technology have entered a stage of great outbreak, and the growth rate of its scientific research has attracted worldwide attention. However, according to Web of Science, the number of English journals in China is only just over 300. Despite its rapid growth, the number of English journals still lags behind the overall scientific research output of China. Therefore, there is a serious imbalance between the scientific research level and the number of international journals in China. One of the fields that have shown rapid growth in China is in the field of infectious microbes and diseases. China has gradually moved to the forefront in our global efforts to combat infectious diseases. Of the 32 new infectious diseases discovered in the world over the past 20 years, about half have emerged in China. Furthermore, China has been at the center of efforts to contain pandemics of Severe Acute Respiratory Syndrome in 2003,4 H1N1 influenza in 20095 and H7N9 influenza in 2013.6 Many of the Chinese scientists responsible for pushing the field teamed-up to jointly establish the Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases (CCID) in 2012. The CCID was housed at the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases in China and has attracted a large number of domestic and foreign outstanding talents. Since its establishment, authors affiliated with CCID have published over 2500 high-quality international research papers, which are estimated to be approximately 1/25th of all high-level publications in the field of infectious diseases containing Chinese authors. Now, CCID decided to launch a new journal in the field of infectious microbes and diseases to help Chinese international publishing grow up to its potential. The new journal “Infectious Microbes & Diseases” will take the open-access model, and will be co-published by Lippincott Williams & Wilkins and Zhejiang University Press on behalf of the CCID and the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases in China. CCID hopes to run a world-class academic journal that promotes the timely and widespread dissemination of research on infectious microbes and diseases, improves the level of diagnosis, treatment, prevention, and control of infectious microbes and diseases, and safeguard human health. The research field of infectious microbes and diseases deserves an excellent platform based in China to publish and rapidly disseminate excellent research, and which is committed to solving the public health and safety problems caused by infectious microbes and diseases globally.
Virology in Peril and the Greater Risk To Science

Michael J. Imperiale,Arturo Casadevall,Felicia D. Goodrum,Stacey Schultz-CherryaDepartment of Microbiology and Immunology,University of Michigan,Ann Arbor,Michigan,USAbDepartment of Microbiology and Immunology,Bloomberg School of Public Health,Johns Hopkins University,Baltimore,Maryland,USAcDepartment of Immunobiology,University of Arizona,Tucson,Arizona,USAdDepartment of Infectious Diseases,St. Jude Children's Research Hospital,Memphis,Tennessee,USA

DOI: https://doi.org/10.1128/msphere.00607-22

2022-12-16

mSphere

Abstract:mSphere, Ahead of Print.

microbiology
Editorial: HPV Natural History, Immunological Responses and Vaccination Strategies: Challenges and Opportunities

Zheng Quan Toh,Fanghui Zhao,Lei Zhang,Lanlan Wei,Huachun Zou

DOI: https://doi.org/10.3389/fimmu.2023.1349664

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:EDITORIAL article Front. Immunol., 08 January 2024Sec. Viral Immunology Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1349664
Virology under the Microscope—a Call for Rational Discourse

Felicia Goodrum,Anice C. Lowen,Seema Lakdawala,James Alwine,Arturo Casadevall,Michael J. Imperiale,Walter Atwood,Daphne Avgousti,Joel Baines,Bruce Banfield,Lawrence Banks,Sumita Bhaduri-McIntosh,Deepta Bhattacharya,Daniel Blanco-Melo,David Bloom,Adrianus Boon,Steeve Boulant,Curtis Brandt,Andrew Broadbent,Christopher Brooke,Craig Cameron,Samuel Campos,Patrizia Caposio,Gary Chan,Anna Cliffe,John Coffin,Kathleen Collins,Blossom Damania,Matthew Daugherty,Kari Debbink,James DeCaprio,Terence Dermody,Jimmy Dikeakos,Daniel DiMaio,Rhoel Dinglasan,W. Paul Duprex,Rebecca Dutch,Nels Elde,Michael Emerman,Lynn Enquist,Bentley Fane,Ana Fernandez-Sesma,Michelle Flenniken,Lori Frappier,Matthew Frieman,Klaus Frueh,Michaela Gack,Marta Gaglia,Tom Gallagher,Denise Galloway,Adolfo García-Sastre,Adam Geballe,Britt Glaunsinger,Stephen Goff,Alexander Greninger,Meaghan Hancock,Eva Harris,Nicholas Heaton,Mark Heise,Ekaterina Heldwein,Brenda Hogue,Stacy Horner,Edward Hutchinson,Joseph Hyser,William Jackson,Robert Kalejta,Jeremy Kamil,Stephanie Karst,Frank Kirchhoff,David Knipe,Timothy Kowalik,Michael Lagunoff,Laimonis Laimins,Ryan Langlois,Adam Lauring,Benhur Lee,David Leib,Shan-Lu Liu,Richard Longnecker,Carolina Lopez,Micah Luftig,Jennifer Lund,Balaji Manicassamy,Grant McFadden,Michael McIntosh,Andrew Mehle,W. Allen Miller,Ian Mohr,Cary Moody,Nathaniel Moorman,Anne Moscona,Bryan Mounce,Joshua Munger,Karl Münger,Eain Murphy,Mojgan Naghavi,Jay Nelson,Christopher Neufeldt,Janko Nikolich,Christine O'Connor,Akira Ono,Walter Orenstein,David Ornelles,Jing-hsiung Ou,John Parker,Colin Parrish,Andrew Pekosz,Philip Pellett,Julie Pfeiffer,Richard Plemper,Stephen Polyak,John Purdy,Dohun Pyeon,Miguel Quinones-Mateu,Rolf Renne,Charles Rice,John Schoggins,Richard Roller,Charles Russell,Rozanne Sandri-Goldin,Martin Sapp,Luis Schang,Scott Schmid,Stacey Schultz-Cherry,Bert Semler,Thomas Shenk,Guido Silvestri,Viviana Simon,Gregory Smith,Jason Smith,Katherine Spindler,Megan Stanifer,Kanta Subbarao,Wesley Sundquist,Mehul Suthar,Troy Sutton,Andrew Tai,Vera Tarakanova,Benjamin tenOever,Scott Tibbetts,Stephen Tompkins,Zsolt Toth,Koenraad van Doorslaer,Marco Vignuzzi,Nicholas Wallace,Derek Walsh,Michael Weekes,Jason Weinberg,Matthew Weitzman,Sandra Weller,Sean Whelan,Elizabeth White,Bryan Williams,Christiane Wobus,Scott Wong,Andrew Yurochko

DOI: https://doi.org/10.1128/jvi.00089-23

IF: 6.549

2023-02-28

Journal of Virology

Abstract:Viruses have brought humanity many challenges: respiratory infection, cancer, neurological impairment and immunosuppression to name a few. Virology research over the last 60+ years has responded to reduce this disease burden with vaccines and antivirals.

virology
Advances in Alphavirus and Flavivirus Research

Young Chan Kim,Arturo Reyes-Sandoval

DOI: https://doi.org/10.3390/v16060882

2024-05-31

Viruses

Abstract:Newly emerging viruses, primarily zoonotic or vector-borne, pose a persistent threat to public health and have led to outbreaks of global concern [...]

virology
New directions for the Journal of Health Psychology

Rachel A Annunziato,Abigail Locke,Gareth J Treharne

DOI: https://doi.org/10.1177/13591053241285169

2024-09-25

Journal of Health Psychology

Abstract:Journal of Health Psychology, Ahead of Print. This editorial reflects on the current and future directions of the Journal of Health Psychology. As the Co-Editors in Chief, we briefly outline our positionality and the importance of our Editorial Board and other peer reviewers in ensuring the rigour of accepted articles. We comment on the middle-ground that has to be struck when considering the scope of open science given that data sharing has to be tempered by ethical and methodological considerations. We re-visit the aims and scope of the journal and reflect on some of the key aspects of diversity that set the journal apart from others. We showcase a selection of Editors' picks that are published in this issue and available as a special collection. The Journal of Health Psychology has a bright future because of the contributions we receive from around the world as well as the outstanding support of peer reviewers.

psychology, clinical
Editorial Board EOV

Niall Adams,Li Cai,Hugh Chipman,Todd Clark,Michael Cohen,Rajeev Dehejia,David van Dyk,Scott Evans,Monserrat Fuentes,Mark Glickman,Jennifer A. Hoeting,Susan Holmes,Nicole Lazar,Roderick Little,Wendy L. Martinez,Daniel McCaffrey,José Pinheiro,Soma Roy,Jun Shao,Roger E. Tourangeau,ASSOCIATE EDITORS,Elena Andreou,Yuichi Kitamura,Hansheng Wang

DOI: https://doi.org/10.1080/07350015.2016.1221617

2016-01-01

Abstract:Committee on Publications Hal Stern, Chair Silvia Goncalves, Member-at-Large Richard A. Levine, Member-at-Large Niall Adams Li Cai Hugh Chipman Todd Clark Michael Cohen Rajeev Dehejia David van Dyk Scott Evans Monserrat Fuentes Mark Glickman Jennifer A. Hoeting Susan Holmes Nicole Lazar Roderick Little Wendy L. Martinez Daniel McCaffrey José Pinheiro Soma Roy Jun Shao Roger E. Tourangeau ASSOCIATE EDITORS
Onwards! Open science and the (PLOS) genetics community

Aimée M. Dudley,Anne Goriely,Julia Squarr

DOI: https://doi.org/10.1371/journal.pgen.1011466

IF: 4.5

2024-11-29

PLoS Genetics

Abstract:Much has changed since 2003 when the Public Library of Science (PLOS) spearheaded the groundbreaking model of open-access publishing that has reshaped the publishing industry. PLOS's vision has always focused on open science and community engagement, and as the first "community journal" in the portfolio, PLOS Genetics has been at the forefront of this pioneering approach. As we step into our new roles as Editors-in-Chief, we would like to reflect on these aspirations and share some initial thoughts on how we hope to build on these important values in the years ahead.

genetics & heredity
How to manage the abundant COVID‐19 submissions to a peer‐reviewed Scientific Journal

Fabrizio Montecucco,Hendrik Nathoe

DOI: https://doi.org/10.1111/eci.13569

2021-04-13

European Journal of Clinical Investigation

Abstract:TABLE 1. Submissions of manuscripts to EJCI from the first year of the new editorial board 2020 as compared to the previous year 2019 Year of submission2020 (N = 1296)2019 (N = 607)SubjectCOVID-19Non-COVID-19Non-COVID-19 (All)Manuscript typeNumber (%)Accept RatioTurnaround timeaa Median turnaround times to first decision vs final decision after external review. (days) NumberAccept ratioTurnaround timeaa Median turnaround times to first decision vs final decision after external review. (days) NumberAccept ratioTurnaround timeaa Median turnaround times to first decision vs final decision after external review. (days) Original118 (60)0.16NA886 (80)0.14NA506 (83)0.12NAReview22 (11)0.31NA116 (11)0.32NA50 (8)0.18NAEditorial/perspective/commentary19 (10)0.52NA39 (4)0.51NA34 (6)0.50NALetter31 (16)0.16NA48 (4)0.45NA12 (2)0.76NAOther5 (3)0.00NA12 (1)0.33NA5 (1)0.60NATotal1950.216 vs 3911010.198 vs 54-Abstract Truncated-

medicine, general & internal, research & experimental
Journal Completes Transition with New Associate Editors

Judith Chow

DOI: https://doi.org/10.1080/10473289.2004.10470928

2004-01-01

Journal of the Air & Waste Management Association

Abstract:" Journal Completes Transition with New Associate Editors." Journal of the Air & Waste Management Association, 54(5), p. 513
Journal of Women's Health Clinical Update

Juliana M Kling,Ekta Kapoor,Stephanie S Faubion

DOI: https://doi.org/10.1089/jwh.2024.0882

2024-09-30

Abstract:The Clinical Update series is intended to help busy clinicians stay up-to-date with recently published important and potentially practice-changing articles on topics pertinent to the care of women. In this update on sexual health, we review studies on the sexual health content of healthcare professional curricula, sexual health and intimacy after cancer in women of color, sexual function in women with polycystic ovarian syndrome, as well as the risks associated with the use of testosterone in women.
Message from the Incoming Editor-in-Chief

Jie Tang

DOI: https://doi.org/10.1109/tbdata.2020.2971766

2020-01-01

IEEE Transactions on Big Data

Abstract:Presents the introductory editorial for this issue of the publication.
Journal of Public Policy & Marketing in Our Turbulent Times: Foundations Laid and Challenges Ahead

Joshua L. Wiener,Pam Scholder Ellen,Scot Burton

DOI: https://doi.org/10.1177/0743915620953443

2020-09-15

Abstract:As we finish our remaining responsibilities as <i>Journal of Public Policy & Marketing</i> editors, we reflect on the changes during the last three years. We then look at the implications for <i>JPP&M</i> of an unprecedented pandemic and its confluence with diverse social justice issues. We close with our suggestions for publishing policy-relevant research.

business
Message from the Outgoing Editor-in-Chief.

W. Zhu

DOI: https://doi.org/10.1109/tmm.2019.2956279

2020-01-01

IEEE Transactions on Big Data

Abstract:Presents the message from the outgoing editor-in-chief for this publication.
Thank you to our reviewers 2022

Kit Sturgess

DOI: https://doi.org/10.18849/ve.v8i1.662

2023-02-17

Veterinary Evidence

Abstract:As 2023, dawns we are faced with a very different world than at the start of 2022, COVID-19 is in the rear-view mirror, but we now face the war in Ukraine, energy prices and inflation. Perhaps this is a glimpse of the ‘new world’ where we will be continually challenged by crisis whether it be conflict, infectious disease or the impacts of global warming. On a more positive note it has been another busy and productive year for Veterinary Evidence as we strive to continually improve the journal whether you are a reader, author or reviewer. In April we said ‘goodbye’ to Daniel Edwards who had covered Bridget Sheppard’s maternity leave as Managing Editor. I would like to take the opportunity to thank Dan for all his hard work for Veterinary Evidence initiating a number of projects that have come to fruition through the year and to welcome Bridget back. As Veterinary Evidence has grown, we have been fortunate to be able to expand our staff to meet the need and ensure efficient turnaround of submissions so another welcome, William Smith has joined the team and is now a permanent full time Editorial Assistant. It is not just staff changes that happened in 2022, we have also improved the governance of Veterinary Evidence with the appointment of new board members and creation of a Deputy Editor-in-Chief position ably filled by Louise Buckley. We also submitted a successful application to COPE (The Committee on Publication Ethics) further strengthening the journal’s oversight and reputation. We have had a major website redesign, now live, which has greatly improved the look, feel, and functionality of Veterinary Evidence for all users. Readers can find relevant papers quickly and efficiently. Our student awards continue to be a success and I would like to thank the whole team of staff and reviewers for turning round these submissions so quickly. I had the pleasure of talking to the prize-winning authors and it was great to hear their enthusiasm but also how much they have valued the help and support from the journal. We have also been developing our processes for reviewing papers to make sure that papers are ready to go out for review. We are working on ways to make sure that, for papers requiring revision, authors respond to each of the comments made by reviewers, and reviewers can quickly see that there has been an author response to their comments and suggestions. A new submission system, Editorial Manager, has been implemented that should make life easier for everyone as well as provide accessible data on papers as they go through the system so we can see what we do well and where we can do better. None of this would be possible without the input from our reviewers and I would like to take this opportunity to say a huge thank you to all our reviewers and everyone who has served on the Editorial Board this year for their tireless efforts on behalf of Veterinary Evidence – without your support the journal could not exist. This year the Board has again had three online meetings, which have been essential in helping develop the strategy for Veterinary Evidence such as how we ensure our Knowledge Summaries remain current, what literature should be included in Knowledge Summaries and how we improve the reviewer and author experience. Once again, a massive thank you to everyone who works for and supports Veterinary Evidence, wishing you all a safe and productive 2023. Kit Sturgess Editor-in-Chief
Clinical Microbiology Reviews: a 21st century vision

Graeme N. Forrest1Rush University Medical Center,Chicago,Illinois,USA

DOI: https://doi.org/10.1128/cmr.00095-24

IF: 36.8

2024-06-21

Clinical Microbiology Reviews

Abstract:Clinical Microbiology Reviews, Ahead of Print.

microbiology

Updates from the Journal of Virology Editors in Chief

2023 Acknowledgment of Journal of Virology Ad Hoc Reviewers

Correction for Rasmussen et al., "Virology—the path forward"

The 15th Anniversary of Viruses: An Unwavering Commitment to Serving the Virology Community

It's time for a booster: here's your 19th dose of Future Virology!

Introducing Our New Journal: Infectious Microbes & Diseases

Virology in Peril and the Greater Risk To Science

Editorial: HPV Natural History, Immunological Responses and Vaccination Strategies: Challenges and Opportunities

Virology under the Microscope—a Call for Rational Discourse

Advances in Alphavirus and Flavivirus Research

New directions for the Journal of Health Psychology

Editorial Board EOV

Onwards! Open science and the (PLOS) genetics community

How to manage the abundant COVID‐19 submissions to a peer‐reviewed Scientific Journal

Journal Completes Transition with New Associate Editors

Journal of Women's Health Clinical Update

Message from the Incoming Editor-in-Chief

Journal of Public Policy & Marketing in Our Turbulent Times: Foundations Laid and Challenges Ahead

Message from the Outgoing Editor-in-Chief.

Thank you to our reviewers 2022

Clinical Microbiology Reviews: a 21st century vision